Brouhaha’s latest production ‘Firebrand’ impresses at Cannes Film Festival
Brouhaha’s latest project impresses at prestigious Cannes Film Festival.
Calculus Capital is a pioneer of tax efficient investing, having launched the UK’s first approved EIS Fund in 1999. We offer an opportunity to invest in a portfolio of entrepreneurial UK growth businesses, through our award winning Calculus EIS Funds and Calculus VCT. We invest in the fastest growing sectors of the UK economy – technology, healthcare and creative industries.
Learn about the tax-efficient investment opportunities offered by our Calculus EIS Fund and Calculus VCT (0% Initial Fee Until 05 April)
We would be delighted to learn about your business and discuss whether Calculus could be a suitable investment partner
Brouhaha’s latest project impresses at prestigious Cannes Film Festival.
This encouraging research programme stems from a collaboration Destiny Pharma has with SporeGen Limited
The collaboration will see a new Phase 1b trial undertaken, investigating OBT’s lead asset, OBT076, in patients with Adenoid Cystic Carcinoma (ACC), a rare and aggressive type of cancer
The grant from the Medical Technology Enterprise Consortium (MTEC) will support the continued development of its fully portable handheld DeepView device